National Institutes of Health to Grant Exclusive License for Hair Growth Treatment

Summary

The National Institutes of Health is considering granting an exclusive license to Lee's Pharmaceutical (Hong Kong) Ltd. to develop and market a treatment for promoting hair growth using actin binding peptides, with the potential territory including China, Hong Kong, and Taiwan.